Can a drug save frostbitten fingers on everest? new study aims to find out
NCT ID NCT07450469
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a medicine called iloprost can be given to people with severe frostbite (grades 3-4) in remote, high-altitude places like Mount Everest. The goal is to see if it's safe and practical to start treatment before reaching a hospital. Ten adults with severe frostbite will receive the drug in the field and be followed for up to 18 months to check if it saves tissue and reduces the need for amputation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALTITUDE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eurac Research, Institute of Mountain Emergency Medicine
Bolzano, BZ, 39100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.
- Altitude may fog your memory for plans
- Lung transplant patients aim for aconcagua summit in landmark altitude study
- Mountain air vs. machine: which altitude experience is more intense?
- Frostbite breakthrough? new drug trial aims to save limbs
- Sous vide device tested for thawing frostbite